HCPCS Level II drug code
J1250 — Injection, dobutamine hydrochloride, per 250 mg
In short
J1250 is the HCPCS Level II code for injection, dobutamine hydrochloride, per 250 mg. CMS assigns NDCs for Dobutamine HCl and Dobutamine HCl In Dextrose to it. One billing unit is 250 mg. The Medicare Part B payment limit is $8.875 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Injection, dobutamine hydrochloride, per 250 mg
- Short descriptor
- Inj dobutamine hcl/250 mg
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 1997
The billing unit is read from the descriptor. Confirm it against the CMS file before billing.
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Units = dose given ÷ 250 mg. For example, 25000 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
NDCs billed under J1250
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 17 NDCs to J1250 for Dobutamine HCl and Dobutamine HCl In Dextrose. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Dobutamine HCl | 00143-9141-10 | Hikma Pharmaceuticals USA Inc. | 10 × 20 | 10 |
| Dobutamine HCl | 00338-1073-02 | Baxter Healthcare Corporation | 18 × 250 | 18 |
| Dobutamine HCl | 00338-1075-02 | Baxter Healthcare Corporation | 18 × 250 | 36 |
| Dobutamine HCl | 00338-1077-02 | Baxter Healthcare Corporation | 18 × 250 | 72 |
| Dobutamine HCl | 00409-2344-01 | Pfizer Inc | 20 | 1 |
| Dobutamine HCl | 00409-2344-02 | Pfizer Inc | 10 × 20 | 10 |
| Dobutamine HCl | 00409-2344-88 | Pfizer Inc | 10 × 20 | 10 |
| Dobutamine HCl | 50090-4562-00 | A-S Medication Solutions | 250 | 4 |
| Dobutamine HCl | 51662-1330-01 | HF Acquisition Co. LLC, DBA HealthFirst | 250 | 2 |
| Dobutamine HCl | 51662-1337-01 | HF Acquisition Co. LLC, DBA HealthFirst | 20 | 1 |
| Dobutamine HCl | 51662-1337-03 | HF Acquisition Co. LLC, DBA HealthFirst | 10 × 20 | 10 |
| Dobutamine HCl | 51662-1566-01 | HF Acquisition Co. LLC, DBA HealthFirst | 250 | 1 |
| Dobutamine HCl | 70436-0203-80 | Slate Run Pharmaceuticals | 20 | 1 |
| Dobutamine HCl | 70436-0203-82 | Slate Run Pharmaceuticals | 10 × 20 | 10 |
| Dobutamine HCl In Dextrose | 00409-0025-10 | Hospira, Inc. | 12 × 250 | 12 |
| Dobutamine HCl In Dextrose | 00409-0151-10 | Hospira, Inc. | 12 × 250 | 24 |
| Dobutamine HCl In Dextrose | 00409-1100-10 | Hospira, Inc. | 12 × 250 | 48 |
J1250: common questions
- Is J1250 a CPT code?
- No. J1250 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J1250?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 17 NDCs under J1250, for Dobutamine HCl and Dobutamine HCl In Dextrose. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J1250?
- $8.875 per 250 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
- What is one billing unit of J1250?
- One unit of J1250 is 250 mg, as stated in the code's descriptor. Units to report = dose given ÷ 250 mg. J-code billing units.